Status:
WITHDRAWN
Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
Trustees of Dartmouth College
Conditions:
CF - Cystic Fibrosis
Cystic Fibrosis-related Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study proposes to examine the relationship between the development of impaired glucose tolerance, the phenotype of CFLD, and risk of liver fibrosis.
Detailed Description
Pancreas insufficiency is a well-established risk factor for development of CF related diabetes (CFRD), but increased insulin resistance has also been demonstrated in this population. Cystic fibrosis ...
Eligibility Criteria
Inclusion
- Men and women ≥ 18 with CF and one of the following:
- Normal OGTT
- Elevated OGTT
- Known CFRD
Exclusion
- Men and women without CF
Key Trial Info
Start Date :
March 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05229640
Start Date
March 31 2022
End Date
December 1 2023
Last Update
July 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756